Johnson & Johnson (JNJ) Exceeds First-quarter Earnings Projections

Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Performing Dow Stocks So Far in 2026.

On April 14, 2026, Reuters reported that Johnson & Johnson (NYSE:JNJ) topped first-quarter earnings projections and raised its full-year forecast. The firm reported revenue of $24.1 billion, above forecasts of $23.6 billion. The adjusted earnings per share were $2.70 as compared to $2.66 projected. Strong demand for Darzalex and Tremfya offset a significant dip in Stelara sales.

Stelara sales fell over 60% year on year to $656 million when the patent expired. Tremfya’s quarterly sales were $1.6 billion, beating the $1.2 billion prediction. Darzalex delivered $4 billion, exceeding the $3.4 billion expectations. According to CFO Joseph Wolk, patients have shifted away from biosimilars in favor of other treatments.

The corporation announced early success with Icotyde, pointing out approximately 1,500 prescriptions within weeks of launch. Johnson & Johnson (NYSE:JNJ) raised its sales forecast for 2026 to a midpoint of $100.8 billion and its adjusted EPS guidance to $11.55. Medical device sales rose by 7.7% to $8.6 billion, matching expectations.

Is Johnson & Johnson (JNJ) the Best Counter Cyclical Stock to Buy Right Now?

Trong Nguyen / Shutterstock.com

Johnson & Johnson (NYSE:JNJ) is a holding corporation that researches, develops, manufactures, and sells healthcare products. It operates through two segments: Innovative Medicine and MedTech.

While we acknowledge the risk and potential of JNJ as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than JNJ and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.